News Novo Nordisk shadows Lilly with insulin price cut plan Danish drugmaker says it will reduce the price of its insulin products in the US by up to 75%.
Market Access Are we entering a new era of blockbuster weight-loss drugs? Has the industry found a new revenue driver in weight-loss treatments?
News Pfizer’s Susan Rienow named new president of ABPI Appointment follows the exit of Novo Nordisk's Pinder Sahota, after firm's ABPI code breaches.
News Sought-after obesity drug Wegovy backed for NHS use Use is restricted to two years in patients enrolled in NHS weight management services.
News Heart hope for Heartseed/Novo Nordisk HS-001 cell therapy Heartseed & Novo Nordisk say a patient has been successfully dosed with cell therapy HS-001.
News Advantage pharma in 340B drug discounting dispute with HHS A federal appeals court in the US has ruled in favour of three pharma companies in a dispute over the supply of discounted medicines to contract pharmacies with the Health
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
